The SARS-CoV-2 IgM assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Alinity i and ARCHITECT i Systems.

  • Used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests
  • The positive agreement between the ARCHITECT i2000sr and the Alinity i was 100.00% and the negative agreement was 99.97%.

The SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top